This is a pilot non-randomized-controlled trial to evaluate the impact of "Tomandocontrol de su salud", an evidenced-based intervention for chronic disease self-managementin the quality of life of patients living with Long-COVID in Puerto Rico.
Patients from our cohort study entitle "The Puerto Rico COVID-19 Assessment Study"
(PR-COAS) (IRB# 2290030465) will be invited to participate in this pilot study during the
12-month follow-up call. Participants with long-COVID and at least one chronic diseases
that agree to participate in the pilot study will be allocated into one of the study
intervention groups that will participate in the "Tomando Control de su Salud" (TCS)
workshops. This group will be asked to answer a final interview approximately one month
after the last workshop. Those not interested in participating in the intervention will
receive general information about chronic disease management available at the CDC website
in Spanish, by email or in person, in addition to their regular health care and will be
asked to answer the interview approximately 3 months after the last interview of the PR
COAS-cohort.
Investigators expect to enroll approximately 50 participants that will be divide between
the groups of intervention and non-intervention. Participants will receive an incentive
for transportation and/or parking expenses and for the time dedicated for their
participation.
Other: "Tomando control de su salud" (Spanish Chronic Disease Self-Management)
"Tomando control de su salud" (Spanish Chronic Disease Self-Management) is a culturally
appropriate program developed in Spanish to support Hispanics patients to build
confidence in their ability to manage their health. This intervention was developed by
Lorig et al. at Stanford University and has been widely used by the Puerto Rico
Department of Health since it is recommended by the CDC as an evidenced-based
intervention for chronic disease management.
Inclusion Criteria:
1. Adult patients 21 years or older;
2. Participant of PR COAS-cohort that completed the last interview (12-month-follow-up)
and authorized to be contacted for further studies;
3. Having at least one chronic condition (excluding cancer) diagnosed by a physician or
healthcare provider, and
4. Ability to attend weekly sessions.
Exclusion Criteria:
1. Any clinical or cognitive impairment that limits the participant's ability to decide
to participate in the study or complete the interviews;
2. presence of a life threatening or extreme medical condition, and
3. planning to move out of the municipality within the next year.
Centro Dotal de Investigaciones de Servicios de Salud, UPR-MSC (Hospital UPR)
Carolina, Puerto Rico
Investigator: Enid J Garcia-Rivera, MD, MPH
Contact: (787) 701-1121
enid.garcia3@upr.edu
Enid J Garcia-Rivera, MD, MPH
(787) 701-1121
enid.garcia3@upr.edu
Maria C Larriuz-Serrano, MS, MPH
(787) 701-1121
maria.larriuz@upr.edu
Enid J Garcia-Rivera, MD, MPH, Principal Investigator
University of Puerto Rico Medical Sciences Campus